The Fluidigm BioMark IFC Controller MX from Fluidigm Europe is a self-contained system specifically designed to automatically prime and load 48.48 Dynamic Array and Digital Array integrated fluidic circuits (IFCs), one at a time.
The MX is a compact, fully integrated system with internal computer, touch screen control, and internal air source capable of setting up 2,304 reactions within minutes. It is the perfect solution for labs undertaking gene expression, genotyping, realtime and digital PCR experiments with lower throughput requirements, tight budgets, and limited bench space.
Fluidgm’s BioMark IFC Controller MX automates the setup of dynamic array or digital array chips. After samples and assays have been pipetted into the inlets of the input frame, the chip is placed onto the controller and with a few taps of the touch screen, samples and assays are loaded into the integrated fluidic circuits,” explained Leila Smith, Director (Business Development) Fluidigm Europe. “After the setup is complete, the IFCs are placed on the BioMark Real-Time PCR system for thermal cycling and data collection. It’s fast and it’s easy.”
The BioMark IFC Controller MX is a fully integrated system that includes built-in software and a self-contained gas source for pressure-loading samples and assays into the dynamic array and digital array chips.
The complete BioMark Molecular Biology System is a combination of IFC chips, instrumentation and applications software that enable scientists to use tried-and-true techniques to accelerate their progress toward answers, at significantly lower costs and labor requirements than traditional methods. Fluidigm’s BioMark Systems represent a fundamental advance in simplicity and throughput over micro well-based systems.
Fluidigm develops, manufactures and markets proprietary Integrated Fluidic Circuit (IFC) systems that significantly improve productivity in life science research. Fluidigm’s IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These “integrated circuits for biology” are made possible by miniaturising and integrating liquid handling components on a single microfabricated microfluidic device. Fluidigm’s IFC systems, consisting of instrumentation, software and single-use IFCs, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems. Fluidigm products have not been cleared or approved by the Food and Drug Administration for use as a diagnostic and are only available for research use.
Filed Under: Drug Discovery